Search research articles
Contact Us
Filters
Showing results (51-60 of 70) with videos related to
Page
of 7
Sort By:
Ecology and Evolution
|
October 24, 2019
Exploring a Pool-seq-only approach for gaining population genomic insights in nonmodel species
Sara Kurland, Christopher W Wheat, Maria de la Paz Celorio Mancera, et al.
Nature Communications
|
December 19, 2019
A transposable element insertion is associated with an alternative life history strategy
Alyssa Woronik, Kalle Tunström, Michael W Perry, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 19, 2003
Array synthesis of novel lipodepsipeptide
James Siedlecki, Jason Hill, Ian Parr, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 19, 2003
Synthesis and biological activity of N-Acylated ornithine analogues of daptomycin
Jason Hill, James Siedlecki, Ian Parr, et al.
Blood Advances
|
April 13, 2018
A next-generation sequencing-based assay for minimal residual disease assessment in AML patients with <i>FLT3</i>-ITD mutations
Mark J Levis, Alexander E Perl, Jessica K Altman, et al.
Molecular Cancer Therapeutics
|
December 24, 2005
Sensitization of DNA damage-induced apoptosis by the proteasome inhibitor PS-341 is p53 dependent and involves target proteins 14-3-3sigma and survivin
Susan A J Vaziri, Jason Hill, Kenichi Chikamori, et al.
Research Square
|
May 2, 2025
Phase separation of NELFE modulates chromatin accessibility to promote dichotomous signaling pathways in hepatocellular carcinoma
Hien Dang, Alvaro Lucci, Anna Barry, et al.
Journal of Cardiopulmonary Rehabilitation and Prevention
|
February 18, 2014
Greater improvement in cardiorespiratory fitness using higher-intensity interval training in the standard cardiac rehabilitation setting
Steven J Keteyian, Brooks A Hibner, Kyle Bronsteen, et al.
Therapeutic Advances in Hematology
|
March 16, 2026
A phase I/II study of gilteritinib in combination with chemotherapy in newly diagnosed patients with AML in Asia: final analysis
Masashi Sawa, Toshihiro Miyamoto, Hee-Je Kim, et al.
International Journal of Hematology
|
November 6, 2024
A phase 1/2 study of gilteritinib in combination with chemotherapy in newly diagnosed patients with AML in Asia
Masashi Sawa, Toshihiro Miyamoto, Hee-Je Kim, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 70) with videos related to
Sort By:
Page
of 7
Ecology and Evolution
|
October 24, 2019
Exploring a Pool-seq-only approach for gaining population genomic insights in nonmodel species
Sara Kurland, Christopher W Wheat, Maria de la Paz Celorio Mancera, et al.
Nature Communications
|
December 19, 2019
A transposable element insertion is associated with an alternative life history strategy
Alyssa Woronik, Kalle Tunström, Michael W Perry, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 19, 2003
Array synthesis of novel lipodepsipeptide
James Siedlecki, Jason Hill, Ian Parr, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 19, 2003
Synthesis and biological activity of N-Acylated ornithine analogues of daptomycin
Jason Hill, James Siedlecki, Ian Parr, et al.
Blood Advances
|
April 13, 2018
A next-generation sequencing-based assay for minimal residual disease assessment in AML patients with <i>FLT3</i>-ITD mutations
Mark J Levis, Alexander E Perl, Jessica K Altman, et al.
Molecular Cancer Therapeutics
|
December 24, 2005
Sensitization of DNA damage-induced apoptosis by the proteasome inhibitor PS-341 is p53 dependent and involves target proteins 14-3-3sigma and survivin
Susan A J Vaziri, Jason Hill, Kenichi Chikamori, et al.
Research Square
|
May 2, 2025
Phase separation of NELFE modulates chromatin accessibility to promote dichotomous signaling pathways in hepatocellular carcinoma
Hien Dang, Alvaro Lucci, Anna Barry, et al.
Journal of Cardiopulmonary Rehabilitation and Prevention
|
February 18, 2014
Greater improvement in cardiorespiratory fitness using higher-intensity interval training in the standard cardiac rehabilitation setting
Steven J Keteyian, Brooks A Hibner, Kyle Bronsteen, et al.
Therapeutic Advances in Hematology
|
March 16, 2026
A phase I/II study of gilteritinib in combination with chemotherapy in newly diagnosed patients with AML in Asia: final analysis
Masashi Sawa, Toshihiro Miyamoto, Hee-Je Kim, et al.
International Journal of Hematology
|
November 6, 2024
A phase 1/2 study of gilteritinib in combination with chemotherapy in newly diagnosed patients with AML in Asia
Masashi Sawa, Toshihiro Miyamoto, Hee-Je Kim, et al.
Page
of 7